New expected objective for treating metastasized oral malignant melanoma in dogs Kumar Jeetendra | April 23, 2021 Scientists have shown that the biological molecule PD-L1 is a possible target for the treatment of metastasized oral malignant melanoma in dogs. There are a number of cancers that affect dogs, but there are far fewer diagnosis and treatment options for these canine cancers. However, because dogs and humans are both mammals, it is very …
Unevenness in gut microbiota could assume a vital part in movement of inflammatory skin disorder Kumar Jeetendra | May 7, 2021 Findings presented at the EADV 2021 Spring Symposium imply that an imbalance in gut microbiota (dysbiosis), could play a substantial role in the progression of inflammatory skin disease, Hidradenitis Suppurativa (HS). HS is a painful, long-term skin condition, with a chronic and relapsing nature that significantly impacts patients’ quality of life. Researchers at Hacettepe University …
Study proposes expected role for probiotics in forestalling respiratory infections Kumar Jeetendra | May 15, 2021 Daily probiotic use was associated with fewer upper respiratory symptoms in overweight and older people, according to a study which suggests a potential role for probiotics in preventing respiratory infections. Researchers re-analyzed detailed daily diaries of 220 patients who engaged in a previous double-blind placebo-controlled study on probiotics and weight loss. Reviewing the entries for …
Study gives significant knowledge to forestalling worldwide pandemics Kumar Jeetendra | May 17, 2021 Whether it’s plankton exposed to parasites or people exposed to pathogens, a host’s initial immune response plays an integral role in determining whether infection occurs and to what level it spreads within a population, new University of Colorado Boulder research indicates. From parasitic flatworms transmitted by snails into individuals in developing nations, to zoonotic spillover …
Mild cases of COVID-19 give enduring antibody, shows study Kumar Jeetendra | May 24, 2021 Months after recovering from mild cases of COVID-19, people still possess immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all of the while. The …
Study recognizes master regulator behind the improvement of antibody delivering cells Kumar Jeetendra | September 24, 2021 The main regulator that controls the production of antibody-producing cells was identified in a research conducted by scientists from Weill Cornell Medicine. These findings offer new insights into the functioning in the immunity system. It also can help to understand how tissues form and how cancers are triggered. The study, which was published on September. …
